CSPC: finished drug business likely to be hindered

Summary: Benefited from the rapid development of finished drug business, CSPChas got rid of the adverse circumstances caused by loss-making VC business. CSPC is likely to encounter an obstacle in transferring API business to drug business.In Q1-Q3 20...

Vitamins China E-News 201511

www.cnchemicals.com